1. Home
  2. ONON vs RGEN Comparison

ONON vs RGEN Comparison

Compare ONON & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo On Holding AG

ONON

On Holding AG

N/A

Current Price

$35.00

Market Cap

11.0B

ML Signal

N/A

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$175.07

Market Cap

11.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ONON
RGEN
Founded
2010
1981
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Shoe Manufacturing
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.0B
11.0B
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
ONON
RGEN
Price
$35.00
$175.07
Analyst Decision
Buy
Buy
Analyst Count
31
20
Target Price
$44.13
★ $203.21
AVG Volume (30 Days)
★ 9.8M
1.2M
Earning Date
11-10-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 286.96
EPS
★ N/A
N/A
Revenue
N/A
★ $141,236,000.00
Revenue This Year
$16.59
$14.98
Revenue Next Year
$18.94
$26.05
P/E Ratio
$56.05
★ N/A
Revenue Growth
N/A
★ 35.10
52 Week Low
$26.37
$100.99
52 Week High
$51.08
$198.87

Technical Indicators

Market Signals
Indicator
ONON
RGEN
Relative Strength Index (RSI) 52.28 48.23
Support Level $31.11 $161.15
Resistance Level $38.73 $188.59
Average True Range (ATR) 1.39 8.49
MACD 0.10 -0.53
Stochastic Oscillator 46.94 38.56

Price Performance

Historical Comparison
ONON
RGEN

About ONON On Holding AG

Founded in Switzerland in 2010, sportswear firm On Holding generates more than 90% of its sales from athletic shoes. The brand is best known for its running shoes and its distinctive CloudTec soles. On also produces athletic apparel (6% of 2025 sales) and accessories (1%). The firm's merchandise is available in more than 80 countries and is sold through both wholesale (58% of sales) and company-owned channels (42%). In 2025, On generated 58% of its sales in North America, 25% in Europe, the Middle East, and Africa, and 17% in the Asia-Pacific region.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: